Clinical Trial Detail

NCT ID NCT01620216
Title Validation of an in Vitro Assay to Predict Targeted Therapies for Acute Leukemia Patients
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Sunitinib

Dasatinib

Nilotinib

Ponatinib

Sorafenib

Age Groups: adult

No variant requirements are available.